Malaria chemosuppression in pregnancy. V. Placenta malarial changes among three different prophylaxis groups

Area of Science:

• Tropical Medicine
• Obstetrics
• Parasitology

Background:

• Malaria during pregnancy poses risks to both mother and fetus.
• Placenta malarial changes (PMCs) are indicators of malaria infection severity.
• Understanding the impact of chemoprophylaxis on PMCs is vital for effective malaria control.

Purpose of the Study:

• To investigate the effect of different malaria chemoprophylaxis regimens on PMCs.
• To compare the prevalence and severity of PMCs across various treatment groups.

Main Methods:

• Analysis of 170 placental tissue sections from pregnant women in a hyperendemic area.
• Comparison of daily proguanil (PROG), weekly chloroquine (CQ), and combination (CQ+PROG) prophylaxis.
• Supervised prophylaxis from early pregnancy to delivery with prompt treatment of parasitaemias.

Main Results:

• PMCs were generally infrequent and mild across all groups.
• No significant differences in PMC type, prevalence, or severity were observed between prophylaxis groups.
• Despite varying prophylactic efficacy, prompt diagnosis and treatment mitigated PMCs in the chloroquine group.

Conclusions:

• Effective malaria chemoprophylaxis or prompt diagnosis and treatment significantly impact PMC prevalence.
• Chemoprophylaxis remains a feasible broad option for malaria control in pregnancy, especially in resource-limited settings.